You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 康寧傑瑞(9966.HK)大漲15%創歷史新高 近一個月升幅超140%
格隆匯 05-24 15:54
格隆匯5月24日丨康寧傑瑞(9966.HK)尾盤拉昇漲15%,報24.8港元創歷史新高價,成交額超4億港元,總市值達230億港元。該股近一個月自歷史低位持續上漲,區間漲幅超140%,短短一個月股價實現反轉創新高。康寧傑瑞製藥近日宣佈,公司自主研發的重組人源化PD-L1單域抗體恩沃利單抗在美國開展的一項關鍵臨牀試驗,將由合作伙伴TRACON Pharmaceuticals在美國時間6月4日-6月8日舉行的2021年美國臨牀腫瘤學會年會上以壁報形式公佈。野村指,公司股價今年的催化劑還有6月4-8日的ASCO結果發表、近期舉辦的投資者日、歐洲腫瘤學學會(ESMO)結果發表及KN026獲批的消息。維持公司“買入”評級,目標價升至28.8港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account